INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Statistics

Total Valuation

INBIOGEN has a market cap or net worth of KRW 118.22 billion. The enterprise value is 117.94 billion.

Market Cap	118.22B
Enterprise Value	117.94B

Important Dates

The last earnings date was Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

INBIOGEN has 9.98 million shares outstanding.

Current Share Class	9.98M
Shares Outstanding	9.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	n/a
Float	2.06M

Valuation Ratios

The trailing PE ratio is 4.52.

PE Ratio	4.52
Forward PE	n/a
PS Ratio	15.15
PB Ratio	0.69
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.54, with an EV/FCF ratio of -31.71.

EV / Earnings	4.51
EV / Sales	15.11
EV / EBITDA	4.54
EV / EBIT	4.64
EV / FCF	-31.71

Financial Position

The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.00.

Current Ratio	2.96
Quick Ratio	2.91
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.20
Interest Coverage	-76.94

Financial Efficiency

Return on equity (ROE) is 16.31% and return on invested capital (ROIC) is -2.13%.

Return on Equity (ROE)	16.31%
Return on Assets (ROA)	-2.11%
Return on Invested Capital (ROIC)	-2.13%
Return on Capital Employed (ROCE)	-3.20%
Revenue Per Employee	190.33M
Profits Per Employee	637.82M
Employee Count	41
Asset Turnover	0.05
Inventory Turnover	32.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.94
52-Week Price Change	n/a
50-Day Moving Average	12,516.00
200-Day Moving Average	10,406.08
Relative Strength Index (RSI)	40.99
Average Volume (20 Days)	14,049

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, INBIOGEN had revenue of KRW 7.80 billion and earned 26.15 billion in profits.

Revenue	7.80B
Gross Profit	-403.72M
Operating Income	-5.48B
Pretax Income	26.15B
Net Income	26.15B
EBITDA	-4.91B
EBIT	-5.48B
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 1.01 billion in cash and 726.44 million in debt, giving a net cash position of 282.81 million or 28.32 per share.

Cash & Cash Equivalents	1.01B
Total Debt	726.44M
Net Cash	282.81M
Net Cash Per Share	28.32
Equity (Book Value)	170.78B
Book Value Per Share	n/a
Working Capital	3.69B

Cash Flow

In the last 12 months, operating cash flow was -3.62 billion and capital expenditures -102.50 million, giving a free cash flow of -3.72 billion.

Operating Cash Flow	-3.62B
Capital Expenditures	-102.50M
Free Cash Flow	-3.72B
FCF Per Share	-372.46

Margins

Gross margin is -5.17%, with operating and profit margins of -70.28% and 335.11%.

Gross Margin	-5.17%
Operating Margin	-70.28%
Pretax Margin	335.11%
Profit Margin	335.11%
EBITDA Margin	-62.88%
EBIT Margin	-70.28%
FCF Margin	n/a

Dividends & Yields

INBIOGEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	22.12%
FCF Yield	-3.15%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 21, 2023. It was a reverse split with a ratio of 0.05.

Last Split Date	Sep 21, 2023
Split Type	Reverse
Split Ratio	0.05

Scores

INBIOGEN has an Altman Z-Score of 24 and a Piotroski F-Score of 2.

Altman Z-Score	24
Piotroski F-Score	2